SE437766B - Forfarande for framstellning av en blandning av en antiinflammatorisk steroid och ett som drivemne anvendbart fluorkolvete - Google Patents
Forfarande for framstellning av en blandning av en antiinflammatorisk steroid och ett som drivemne anvendbart fluorkolveteInfo
- Publication number
- SE437766B SE437766B SE8103143A SE8103143A SE437766B SE 437766 B SE437766 B SE 437766B SE 8103143 A SE8103143 A SE 8103143A SE 8103143 A SE8103143 A SE 8103143A SE 437766 B SE437766 B SE 437766B
- Authority
- SE
- Sweden
- Prior art keywords
- propellant
- steroid
- mixture
- process according
- suspended
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 14
- 239000000203 mixture Substances 0.000 title claims description 10
- 239000002260 anti-inflammatory agent Substances 0.000 title claims 2
- 239000000446 fuel Substances 0.000 title 1
- 239000002245 particle Substances 0.000 claims description 15
- 239000003380 propellant Substances 0.000 claims description 13
- CYRMSUTZVYGINF-UHFFFAOYSA-N trichlorofluoromethane Chemical compound FC(Cl)(Cl)Cl CYRMSUTZVYGINF-UHFFFAOYSA-N 0.000 claims description 12
- 229940029284 trichlorofluoromethane Drugs 0.000 claims description 12
- 150000003431 steroids Chemical class 0.000 claims description 9
- 239000000725 suspension Substances 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 6
- 239000004338 Dichlorodifluoromethane Substances 0.000 claims description 5
- PXBRQCKWGAHEHS-UHFFFAOYSA-N dichlorodifluoromethane Chemical compound FC(F)(Cl)Cl PXBRQCKWGAHEHS-UHFFFAOYSA-N 0.000 claims description 5
- 235000019404 dichlorodifluoromethane Nutrition 0.000 claims description 5
- 239000012528 membrane Substances 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 239000004215 Carbon black (E152) Substances 0.000 claims 1
- UMNKXPULIDJLSU-UHFFFAOYSA-N dichlorofluoromethane Chemical compound FC(Cl)Cl UMNKXPULIDJLSU-UHFFFAOYSA-N 0.000 claims 1
- 229940099364 dichlorofluoromethane Drugs 0.000 claims 1
- -1 fluorocarbon hydrocarbon Chemical class 0.000 claims 1
- 229930195733 hydrocarbon Natural products 0.000 claims 1
- 239000013078 crystal Substances 0.000 description 11
- KUVIULQEHSCUHY-XYWKZLDCSA-N Beclometasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)COC(=O)CC)(OC(=O)CC)[C@@]1(C)C[C@@H]2O KUVIULQEHSCUHY-XYWKZLDCSA-N 0.000 description 5
- 229950000210 beclometasone dipropionate Drugs 0.000 description 5
- 238000004090 dissolution Methods 0.000 description 5
- 238000000227 grinding Methods 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 238000001914 filtration Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000007792 addition Methods 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000000889 atomisation Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000002178 crystalline material Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000012453 solvate Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K3/00—Materials not provided for elsewhere
- C09K3/30—Materials not provided for elsewhere for aerosols
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Dispersion Chemistry (AREA)
- Otolaryngology (AREA)
- Materials Engineering (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI801610A FI63672C (fi) | 1980-05-19 | 1980-05-19 | Foerfarande foer framstaellning av en blandning av beklometasondipropionat och triklorfluormetan eller diklordifluormetan |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE8103143L SE8103143L (sv) | 1981-11-20 |
| SE437766B true SE437766B (sv) | 1985-03-18 |
Family
ID=8513487
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE8103143A SE437766B (sv) | 1980-05-19 | 1981-05-19 | Forfarande for framstellning av en blandning av en antiinflammatorisk steroid och ett som drivemne anvendbart fluorkolvete |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US4347236A (cs) |
| JP (1) | JPS5716820A (cs) |
| AT (1) | AT380791B (cs) |
| BE (1) | BE888822A (cs) |
| CA (1) | CA1162852A (cs) |
| CH (1) | CH647408A5 (cs) |
| CS (1) | CS221831B2 (cs) |
| DD (1) | DD158856A5 (cs) |
| DE (1) | DE3119745A1 (cs) |
| DK (1) | DK218481A (cs) |
| ES (1) | ES8203606A1 (cs) |
| FI (1) | FI63672C (cs) |
| FR (1) | FR2482457A1 (cs) |
| GB (1) | GB2076422B (cs) |
| HU (1) | HU188093B (cs) |
| NL (1) | NL8102457A (cs) |
| NO (1) | NO155429C (cs) |
| PL (1) | PL127872B1 (cs) |
| PT (1) | PT72989B (cs) |
| SE (1) | SE437766B (cs) |
| SU (1) | SU1184428A3 (cs) |
Cited By (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5653962A (en) * | 1991-12-12 | 1997-08-05 | Glaxo Group Limited | Aerosol formulations containing P134a and particulate medicaments |
| US5658549A (en) * | 1991-12-12 | 1997-08-19 | Glaxo Group Limited | Aerosol formulations containing propellant 134a and fluticasone propionate |
| US5674472A (en) * | 1991-12-12 | 1997-10-07 | Glaxo Group Limited | Canisters containing aerosol formulations containing P134a and fluticasone propionate |
| US5674471A (en) * | 1991-12-12 | 1997-10-07 | Glaxo Group Limited | Aerosol formulations containing P134a and salbutamol |
| US5736124A (en) * | 1991-12-12 | 1998-04-07 | Glaxo Group Limited | Aerosol formulations containing P134a and particulate medicament |
| US5744123A (en) * | 1991-12-12 | 1998-04-28 | Glaxo Group Limited | Aerosol formulations containing P134a and particulate medicaments |
| US6200549B1 (en) | 1991-12-12 | 2001-03-13 | Glaxo Group Limited | Aerosol formulation containing P134a and particulate medicament |
| US6333023B1 (en) | 1991-12-12 | 2001-12-25 | Glaxo Group Limited | Aerosol formulation containing particulate formoterol, propellant and polar cosolvent |
| US6743413B1 (en) | 1991-12-18 | 2004-06-01 | 3M Company | Suspension aerosol formulations |
| US7101534B1 (en) | 1991-12-18 | 2006-09-05 | 3M Innovative Properties Company | Suspension aerosol formulations |
| US7105152B1 (en) | 1991-12-18 | 2006-09-12 | 3M Innovative Properties Company | Suspension aerosol formulations |
| US7994197B2 (en) | 2007-02-11 | 2011-08-09 | Map Pharmaceuticals, Inc. | Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile |
| US8080236B2 (en) | 2002-04-17 | 2011-12-20 | Nektar Therapeutics Uk, Ltd | Particulate materials |
| US9394314B2 (en) | 2012-12-21 | 2016-07-19 | Map Pharmaceuticals, Inc. | 8′-hydroxy-dihydroergotamine compounds and compositions |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR890000664B1 (ko) * | 1981-10-19 | 1989-03-22 | 바리 안소니 뉴우샘 | 미분된 베클로메타손 디프로피오네이트 일수화물의 제조방법 |
| US4863720A (en) * | 1986-03-10 | 1989-09-05 | Walter Burghart | Pharmaceutical preparation and methods for its production |
| JPH01156916A (ja) * | 1987-09-25 | 1989-06-20 | Ss Pharmaceut Co Ltd | 肝疾患治療剤 |
| GB9202519D0 (en) * | 1992-02-06 | 1992-03-25 | Glaxo Group Ltd | Medicaments |
| US5376359A (en) * | 1992-07-07 | 1994-12-27 | Glaxo, Inc. | Method of stabilizing aerosol formulations |
| MX9304585A (es) * | 1992-07-31 | 1994-03-31 | Glaxo Group Ltd | Formulacion farmaceutica en aerosol, lata adecuada para liberar la formulacion e inhalador de dosis dosificada que comprende la lata. |
| US7582284B2 (en) | 2002-04-17 | 2009-09-01 | Nektar Therapeutics | Particulate materials |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE629985A (cs) * | 1962-11-29 | |||
| GB1429184A (en) * | 1972-04-20 | 1976-03-24 | Allen & Hanburys Ltd | Physically anti-inflammatory steroids for use in aerosols |
| JPS531814A (en) * | 1976-06-28 | 1978-01-10 | Toshiba Corp | Control unit of induction motor |
| US4225597A (en) * | 1976-10-01 | 1980-09-30 | Schering Corporation | Beclomethasone dipropionate-hexane solvate and aerosols prepared therefrom |
| IT1121513B (it) * | 1979-05-28 | 1986-04-02 | Chiesi Farma Spa | Processo per la conversione di umo steroide antiinfiammatorio in una forma suscettibile di essere somministarta come aerosol |
-
1980
- 1980-05-19 FI FI801610A patent/FI63672C/fi not_active IP Right Cessation
-
1981
- 1981-04-21 AT AT0179181A patent/AT380791B/de not_active IP Right Cessation
- 1981-04-24 GB GB8112683A patent/GB2076422B/en not_active Expired
- 1981-04-29 CA CA000376540A patent/CA1162852A/en not_active Expired
- 1981-05-06 PT PT72989A patent/PT72989B/pt unknown
- 1981-05-15 FR FR8109719A patent/FR2482457A1/fr active Granted
- 1981-05-15 BE BE0/204802A patent/BE888822A/fr unknown
- 1981-05-15 CH CH3165/81A patent/CH647408A5/de not_active IP Right Cessation
- 1981-05-18 SU SU813283353A patent/SU1184428A3/ru active
- 1981-05-18 CS CS813676A patent/CS221831B2/cs unknown
- 1981-05-18 HU HU811405A patent/HU188093B/hu unknown
- 1981-05-18 DE DE19813119745 patent/DE3119745A1/de not_active Withdrawn
- 1981-05-18 DK DK218481A patent/DK218481A/da not_active Application Discontinuation
- 1981-05-18 PL PL1981231220A patent/PL127872B1/pl unknown
- 1981-05-18 ES ES502286A patent/ES8203606A1/es not_active Expired
- 1981-05-18 DD DD81230036A patent/DD158856A5/de unknown
- 1981-05-18 NO NO811686A patent/NO155429C/no unknown
- 1981-05-19 NL NL8102457A patent/NL8102457A/nl not_active Application Discontinuation
- 1981-05-19 JP JP7433181A patent/JPS5716820A/ja active Pending
- 1981-05-19 US US06/265,333 patent/US4347236A/en not_active Expired - Fee Related
- 1981-05-19 SE SE8103143A patent/SE437766B/sv not_active IP Right Cessation
Cited By (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6919069B2 (en) | 1991-12-12 | 2005-07-19 | Glaxo Group Limited | Aerosol formulation containing particulate formoterol, propellant and polar cosolvent |
| US6303103B1 (en) | 1991-12-12 | 2001-10-16 | Glaxo Group Limited | Aerosols containing salmeterol xinafoate and an anticholinergic medicament |
| US5674472A (en) * | 1991-12-12 | 1997-10-07 | Glaxo Group Limited | Canisters containing aerosol formulations containing P134a and fluticasone propionate |
| US5674471A (en) * | 1991-12-12 | 1997-10-07 | Glaxo Group Limited | Aerosol formulations containing P134a and salbutamol |
| US5736124A (en) * | 1991-12-12 | 1998-04-07 | Glaxo Group Limited | Aerosol formulations containing P134a and particulate medicament |
| US5744123A (en) * | 1991-12-12 | 1998-04-28 | Glaxo Group Limited | Aerosol formulations containing P134a and particulate medicaments |
| US6200549B1 (en) | 1991-12-12 | 2001-03-13 | Glaxo Group Limited | Aerosol formulation containing P134a and particulate medicament |
| US6238647B1 (en) | 1991-12-12 | 2001-05-29 | Glaxo Group Limited | Aerosol formulations containing salmeterol xinafoate, an anticholinergic agent and tetrafluoroethane |
| US6251368B1 (en) | 1991-12-12 | 2001-06-26 | Glaxo Group Limited | Pharmaceutical aerosol formulation containing a particulate medicament, a propellant and substantially free of a surfactant |
| US7498020B2 (en) | 1991-12-12 | 2009-03-03 | Glaxo Group Limited | Medicaments |
| US6306369B1 (en) | 1991-12-12 | 2001-10-23 | Glaxo Group Limited | Aerosol formulations containing P134a and particulate medicament |
| US6333023B1 (en) | 1991-12-12 | 2001-12-25 | Glaxo Group Limited | Aerosol formulation containing particulate formoterol, propellant and polar cosolvent |
| US5653962A (en) * | 1991-12-12 | 1997-08-05 | Glaxo Group Limited | Aerosol formulations containing P134a and particulate medicaments |
| US6893628B2 (en) | 1991-12-12 | 2005-05-17 | Glaxo Group Limited | Aerosol formulations containing P134a and particulate medicament |
| US5658549A (en) * | 1991-12-12 | 1997-08-19 | Glaxo Group Limited | Aerosol formulations containing propellant 134a and fluticasone propionate |
| US7105152B1 (en) | 1991-12-18 | 2006-09-12 | 3M Innovative Properties Company | Suspension aerosol formulations |
| US6743413B1 (en) | 1991-12-18 | 2004-06-01 | 3M Company | Suspension aerosol formulations |
| US7101534B1 (en) | 1991-12-18 | 2006-09-05 | 3M Innovative Properties Company | Suspension aerosol formulations |
| US8080236B2 (en) | 2002-04-17 | 2011-12-20 | Nektar Therapeutics Uk, Ltd | Particulate materials |
| US8470301B2 (en) | 2002-04-17 | 2013-06-25 | Nektar Therapeutics | Particulate materials |
| US8828359B2 (en) | 2002-04-17 | 2014-09-09 | Nektar Therapeutics | Particulate materials |
| US9616060B2 (en) | 2002-04-17 | 2017-04-11 | Nektar Therapeutics | Particulate materials |
| US10251881B2 (en) | 2002-04-17 | 2019-04-09 | Nektar Therapeutics | Particulate materials |
| US7994197B2 (en) | 2007-02-11 | 2011-08-09 | Map Pharmaceuticals, Inc. | Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile |
| US8119639B2 (en) | 2007-02-11 | 2012-02-21 | Map Pharmaceuticals, Inc. | Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile |
| US8148377B2 (en) | 2007-02-11 | 2012-04-03 | Map Pharmaceuticals, Inc. | Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile |
| US9833451B2 (en) | 2007-02-11 | 2017-12-05 | Map Pharmaceuticals, Inc. | Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile |
| US10172853B2 (en) | 2007-02-11 | 2019-01-08 | Map Pharmaceuticals, Inc. | Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile |
| US9394314B2 (en) | 2012-12-21 | 2016-07-19 | Map Pharmaceuticals, Inc. | 8′-hydroxy-dihydroergotamine compounds and compositions |
Also Published As
| Publication number | Publication date |
|---|---|
| SE8103143L (sv) | 1981-11-20 |
| DD158856A5 (de) | 1983-02-09 |
| DE3119745A1 (de) | 1982-02-11 |
| US4347236A (en) | 1982-08-31 |
| GB2076422A (en) | 1981-12-02 |
| NO155429B (no) | 1986-12-22 |
| FI63672C (fi) | 1983-08-10 |
| HU188093B (en) | 1986-03-28 |
| PT72989A (en) | 1981-06-01 |
| AT380791B (de) | 1986-07-10 |
| PL127872B1 (en) | 1983-12-31 |
| CH647408A5 (de) | 1985-01-31 |
| NO811686L (no) | 1981-11-20 |
| GB2076422B (en) | 1983-12-14 |
| CA1162852A (en) | 1984-02-28 |
| DK218481A (da) | 1981-11-20 |
| FI63672B (fi) | 1983-04-29 |
| ES502286A0 (es) | 1982-04-01 |
| ES8203606A1 (es) | 1982-04-01 |
| PL231220A1 (cs) | 1982-01-18 |
| FR2482457A1 (fr) | 1981-11-20 |
| SU1184428A3 (ru) | 1985-10-07 |
| JPS5716820A (en) | 1982-01-28 |
| CS221831B2 (en) | 1983-04-29 |
| PT72989B (en) | 1983-07-06 |
| NO155429C (no) | 1987-04-01 |
| FR2482457B1 (cs) | 1985-01-04 |
| ATA179181A (de) | 1985-12-15 |
| FI801610A7 (fi) | 1981-11-20 |
| NL8102457A (nl) | 1981-12-16 |
| BE888822A (fr) | 1981-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE437766B (sv) | Forfarande for framstellning av en blandning av en antiinflammatorisk steroid och ett som drivemne anvendbart fluorkolvete | |
| KR910004338B1 (ko) | 에어로졸로 사용하기 적합한, 물리적 변성 베클로메타손 디프로피오네이트 | |
| IL42038A (en) | Antiinflammatory steroids in the form of crystalline solvates and aerosol formulations containing them | |
| EP0039369B1 (en) | Beclomethasone ester solvates, process for their preparation, and preparation of a formulation | |
| JP2009523780A (ja) | メソトリオンの結晶化方法 | |
| HRP20050803A2 (en) | Novel crystalline modification of the anhydrate of boscalid | |
| EP0172672B1 (en) | Preparation and use of new solvates of beclomethasone 17,21-diproprionate | |
| CA1087958A (en) | Process for the preparation of concentrated suspensions | |
| Head | Ice nucleation by some cyclic compounds | |
| NL8003049A (nl) | Werkwijze voor het omzetten van een ontsteking werend steroide in een voor toediening met aerosol geschikte vorm. | |
| BG97767A (bg) | Бензендиметанол,подходящ за микронизиране | |
| CN113476646A (zh) | 一种用于德莫林皮肤敷料的复合抛射体系 | |
| Hettiarachchy et al. | Isolation and characterization of mitochondrial deoxyribonucleic acid of Acanthamoeba castellanii | |
| US2167272A (en) | Process of producing crystalline ergosterol | |
| FI67299B (fi) | Foerfarande foer framstaellning av ett alkansolvat av beklometasondipropionat | |
| CN120271581A (zh) | 一种异噁唑啉脲嘧啶类化合物的结晶方法及其应用 | |
| JPH03178990A (ja) | クロロフルオロカーボンを基剤とした微細結晶計量エアゾールでの使用に適する特別の結晶性向を示すジプロピオン酸ベクロメタゾンの製造方法 | |
| CA2888904A1 (en) | Method for enlarging the particle size of crystalline microparticles of active substance | |
| NO180676B (no) | 1-hydroksy-2-naftalenkarboksylat(hydroksynaftoat)-salt av 4-hydroksy-<alfa>1 £££6-(4-fenylbutoksy)-heksyl|amino|metyl|-1,3-benzendimetanol og fremgangsmåte for fremstilling derav | |
| CN106573875A (zh) | 钆贝葡胺的固体形式的制备 | |
| US20080096970A1 (en) | Stable Nateglinide Form B Compositions | |
| JPS62168539A (ja) | カプセルの製法 | |
| CN116693410A (zh) | 一种粒径可控的加巴喷丁制备方法 | |
| JPS5824525A (ja) | 難固化性物質の製造法 | |
| JPH0129199B2 (cs) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NUG | Patent has lapsed |
Ref document number: 8103143-7 Effective date: 19900518 Format of ref document f/p: F |